These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 21638287)

  • 1. Effect of cardiac resynchronization therapy on libido and erectile dysfunction.
    Vural A; Agacdiken A; Celikyurt U; Culha M; Kahraman G; Kozdag G; Ural D
    Clin Cardiol; 2011 Jul; 34(7):437-41. PubMed ID: 21638287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The association between cardiac resynchronization therapy response and sexual activity in patients with heart failure.
    Kuyumcu MS; Alagöz M; Yayla Ç; Ünal S; Özbay MB; Acar B; Yakut İ; Erbay İ
    Hellenic J Cardiol; 2020; 61(1):34-39. PubMed ID: 30170020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiac resynchronization therapy in patients with heart failure and moderately reduced ejection fraction: Could it trigger a super-response?
    Tawfik Ghanem M; Allam LE; Samir Ahmed R
    Indian Heart J; 2019; 71(3):229-234. PubMed ID: 31543195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized trial of cardiac resynchronization in mildly symptomatic heart failure patients and in asymptomatic patients with left ventricular dysfunction and previous heart failure symptoms.
    Linde C; Abraham WT; Gold MR; St John Sutton M; Ghio S; Daubert C;
    J Am Coll Cardiol; 2008 Dec; 52(23):1834-1843. PubMed ID: 19038680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endothelial dysfunction is a marker of systemic response to the cardiac resynchronization therapy in heart failure.
    Santini L; Capria A; Di Molfetta A; Mahfouz K; Panattoni G; Minni V; Sergi D; Forleo GB; Romeo F
    J Card Fail; 2013 Jun; 19(6):419-25. PubMed ID: 23743492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal function impairment predicts mortality in patients with chronic heart failure treated with resynchronization therapy.
    Gronda E; Genovese S; Padeletti L; Cacciatore F; Vitale DF; Bragato R; Innocenti L; Schiano C; Sommese L; De Pascale MR; Genovese L; Abete P; Donatelli F; Napoli C
    Cardiol J; 2015; 22(4):459-66. PubMed ID: 26325259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reverse electrical remodeling by cardiac resynchronization therapy: prevalence and clinical impact.
    Sebag FA; Martins RP; Defaye P; Hidden-Lucet F; Mabo P; Daubert JC; Leclercq C
    J Cardiovasc Electrophysiol; 2012 Nov; 23(11):1219-27. PubMed ID: 22697464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term impact of cardiac resynchronization therapy in mild heart failure: 5-year results from the REsynchronization reVErses Remodeling in Systolic left vEntricular dysfunction (REVERSE) study.
    Linde C; Gold MR; Abraham WT; St John Sutton M; Ghio S; Cerkvenik J; Daubert C;
    Eur Heart J; 2013 Sep; 34(33):2592-9. PubMed ID: 23641006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Baseline aortic pre-ejection interval predicts reverse remodeling and clinical improvement after cardiac resynchronization therapy.
    Aksoy H; Okutucu S; Aytemir K; Kaya EB; Evranos B; Kabakci G; Tokgozoglu L; Ozkutlu H; Oto A
    Cardiol J; 2011; 18(6):639-47. PubMed ID: 22113751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How does ivabradine effect erectile dysfunction in patients with heart failure?
    Aydın F; Bektur S; Taşdelen Y; Kıvrak Y; Hüseyinoglu Aydın A
    Kardiol Pol; 2017; 75(9):893-898. PubMed ID: 28541595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Left ventricular ejection fraction normalization in cardiac resynchronization therapy and risk of ventricular arrhythmias and clinical outcomes: results from the Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy (MADIT-CRT) trial.
    Ruwald MH; Solomon SD; Foster E; Kutyifa V; Ruwald AC; Sherazi S; McNitt S; Jons C; Moss AJ; Zareba W
    Circulation; 2014 Dec; 130(25):2278-86. PubMed ID: 25301831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of super-response to cardiac resynchronization therapy and associated improvement in clinical outcome: the MADIT-CRT (multicenter automatic defibrillator implantation trial with cardiac resynchronization therapy) study.
    Hsu JC; Solomon SD; Bourgoun M; McNitt S; Goldenberg I; Klein H; Moss AJ; Foster E;
    J Am Coll Cardiol; 2012 Jun; 59(25):2366-73. PubMed ID: 22698490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Echocardiographic phase imaging to predict reverse remodeling after cardiac resynchronization therapy.
    Buss SJ; Humpert PM; Bekeredjian R; Hardt SE; Zugck C; Schellberg D; Bauer A; Filusch A; Kuecherer H; Katus HA; Korosoglou G
    JACC Cardiovasc Imaging; 2009 May; 2(5):535-43. PubMed ID: 19442937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in parameters of right ventricular function with cardiac resynchronization therapy.
    Sharma A; Lavie CJ; Vallakati A; Garg A; Goel S; Lazar J; Fonarow GC
    Clin Cardiol; 2017 Nov; 40(11):1033-1043. PubMed ID: 28898433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of ejection fraction on the clinical response to cardiac resynchronization therapy in mild heart failure.
    Linde C; Daubert C; Abraham WT; St John Sutton M; Ghio S; Hassager C; Herre JM; Bergemann TL; Gold MR;
    Circ Heart Fail; 2013 Nov; 6(6):1180-9. PubMed ID: 24014828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute effects of cardiac resynchronization therapy on arterial distensibility and serum norepinephrine levels in advanced heart failure.
    Yildiz M; Hasdemir H; Turkkan C; Astarcioglu MA; Alper AT; Sahin A; Ozkan M
    Cardiol J; 2013; 20(3):304-9. PubMed ID: 23788305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Baroreflex activation therapy for the treatment of heart failure with a reduced ejection fraction: safety and efficacy in patients with and without cardiac resynchronization therapy.
    Zile MR; Abraham WT; Weaver FA; Butter C; Ducharme A; Halbach M; Klug D; Lovett EG; Müller-Ehmsen J; Schafer JE; Senni M; Swarup V; Wachter R; Little WC
    Eur J Heart Fail; 2015 Oct; 17(10):1066-74. PubMed ID: 26011593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relation between cardiac 123I-mIBG scintigraphy and functional response 1 year after CRT implantation.
    Verschure DO; Poel E; De Vincentis G; Frantellizzi V; Nakajima K; Gheysens O; de Groot JR; Verberne HJ
    Eur Heart J Cardiovasc Imaging; 2021 Jan; 22(1):49-57. PubMed ID: 32259839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiac resynchronization therapy is associated with a reduction in ICD therapies as it improves ventricular function.
    Galve E; Oristrell G; Acosta G; Ribera-Solé A; Moya-Mitjans À; Ferreira-González I; Pérez-Rodon J; García-Dorado D
    Clin Cardiol; 2018 Jun; 41(6):803-808. PubMed ID: 29604094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic effect and modulation of cardiac sympathetic function in heart failure patients treated with cardiac resynchronization therapy.
    Moreira RI; Abreu A; Portugal G; Oliveira L; Oliveira M; Rodrigues I; Cruz MC; Cunha PS; Santos V; Clara HS; Carmo MM; Ferreira RC
    J Nucl Cardiol; 2020 Feb; 27(1):283-290. PubMed ID: 29992524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.